Skip to main content
Clinical Trials/TCTR20190822001
TCTR20190822001
Recruiting
未知

Evaluation of left atrial(LA) function using left atrial fractional area change (LAFAC) as a diagnostic tool for cardiac amyloidosis

Faculty of Medicine, Chiang Mai University0 sites80 target enrollmentAugust 22, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Heart failure preserved LVEFcardiac amyloidosisHypertensive heart disease (HT heart disease)Hypertrophic cardiomyopathy (HCM)Constrictive pericarditisLeft atrial fractional area change (LAFA
Sponsor
Faculty of Medicine, Chiang Mai University
Enrollment
80
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 22, 2019
End Date
May 31, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Faculty of Medicine, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients diagnosed cardiac amyloidosis confirmed diagnostic criteria and tissue or bone marrow biopsy showing amyloid deposit.
  • 2\. Echocardiography findings concomitant with cardiac amyloidosis and diagnosed by at least two experienced cardiologists.
  • 3\. Hypertensive heart disease patients with LVH(LVMI\>115g/m2in male or \> 95 g/m2 in female with RWT \> 0\.42\) and age matched to patients in cardiac amyloidosis group.
  • 4\. HCM patients with LVH(LVMI\>115g/m2 in male or\>95g/m2in female with RWT \> 0\.42\)
  • 5\. Constrictive pericarditis patients with echocardiographic finding concomitant with Mayo Clinic echocardiographic criteria and diagnosed by at least two experienced cardiologists.
  • 6\. Healthy subjects without heart disease with age matched with patients in cardiac amyloidosis group

Exclusion Criteria

  • 1\. Inadequate quality or unavailable echocardiographic study
  • 2 . Patients with atrial fibrillation

Outcomes

Primary Outcomes

Not specified

Similar Trials